Another EASD annual meeting presentation showed that tirzepatide was better than semaglutide for controlling blood sugar and weight loss
A need for more treatments Those of us doing work in this area see this as a step in the right direction, Christian Hendershot, an assistant professor in the Department of Psychiatry and Bowles Center of Alcohol Studies at the University of North Carolina at Chapel Hill, who is running one of the few studies in this area, said by email Wednesday
Those interested in additional support for the fat loss phase can also review the supplements to take with GLP-1 guide and the best peptide stack for weight loss resource, which covers how different compounds can be combined with GLP-1 medications for enhanced outcomes
It goes one step further as a triple-agonist, targeting GLP-1, GIP, and glucagon receptors, which may enhance fat metabolism
Yes, GLP-1 receptor agonists like semaglutide and tirzepatide are generally safe for patients with fatty liver disease and are not contraindicated in MASLD
Our research integrates classical microbiology, whole genome sequencing, metagenomics, emerging molecular detection approaches, and targeted phenotypic analyses
